Cardio-Oncology Consultations for Cancer
(CARMA Trial)

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byKatelyn Atkins, MD, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Cedars-Sinai Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this study is to examine adherence to cardio-oncology consultation.

Eligibility Criteria

This trial is for people with any stage of cancer (I-IV) who are about to receive high-dose radiotherapy (≥30 Gy) that includes the heart in its treatment area. Participants should be relatively active and mobile (ECOG 0-2), able to use a smart device, understand English, and follow study procedures.

Inclusion Criteria

I am planning to undergo standard radiotherapy treatments.

I can take care of myself and am up and about more than half of the day.

My cancer treatment includes high dose radiation affecting my heart.

+3 more

Exclusion Criteria

I have not had a heart attack in the last 6 months.

I have severe or active scleroderma or lupus.

You are allergic to metal used in surgery or rubber materials.

Participant Groups

The CARMA Trial is testing how well patients stick to a cardio-oncology consultation plan designed to reduce heart risks during thoracic radiotherapy treatments for cancer.

1Treatment groups

Experimental Treatment

Group I: CARMAExperimental Treatment1 Intervention

Cardiac Aggressive Risk MitigAtion plan with biosensor monitoring